Evidence map›Paper›PMID 42096146›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Generating Targeted Mutants Using a Riboswitch to Control Plasmid Behavior During Allelic Exchange Mutagenesis.

Joshua N Brehm, Joseph A Sorg

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joshua N BrehmDepartment of Biology, Texas A&M University, College Station, TX, USA.
Joseph A SorgDepartment of Biology, Texas A&M University, College Station, TX, USA. jsorg@bio.tamu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficient and markerless allele-coupled exchange (ACE) mutagenesis is possible in a wild-type C. difficile background by using a synthetic riboswitch to indirectly control replication of the mutagenesis plasmid. Controlling plasmid replication gives the user the ability to introduce selective pressure for recombination of the mutagenesis plasmid into the chromosome (integration) followed by recombination of plasmid DNA out of the chromosome (excision) reliably. ACE has been successfully used in C. difficile research for over a decade, mostly with unstably replicating plasmids using toxic pyrimidine precursors or toxin/antitoxin systems to select for recombination events. The advantages of using a riboswitch to control plasmid replication include the ability to begin with a wild-type parent strain, use of a higher copy number origin of replication, and generation of mutants on rich medium. A wild-type progenitor means there is no need to complement pyrE into newly made mutants, increasing ease of use. The inclusion of the more stable, pCD6-derived origin of replication in the mutagenesis vector should increase efficiency of conjugal transfer, and its higher plasmid copy number should increase the frequency of crossover events. The efficacy of the riboswitch in rich media also avoids the use of minimal or defined media, increasing growth rates and ease of use.

Indexed as

Clostridioides difficileMutagenesisMutationPlasmidsRiboswitchAllelesDNA ReplicationRiboswitchAllelic exchange mutagenesisRiboswitchTargeted mutations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.